Similar articles

• Clinical evaluation of arterial administration of SMANCS in oily contrast medium for liver cancer.

  Tashiro S, Maeda H. Tashiro S, et al. Jpn J Med. 1985 Feb;24(1):79-80. doi: 10.2169/internalmedicine1962.24.79. Jpn J Med. 1985. PMID: 2987585 No abstract available.
• [Computed tomography after administration of SMANCS-lipiodol to liver cancers].

  Maki S, Konno T, Iwai K, Uchida M, Tashiro S, Miyauchi Y, Maeda H. Maki S, et al. Nihon Gan Chiryo Gakkai Shi. 1984 Aug 20;19(7):1443-9. Nihon Gan Chiryo Gakkai Shi. 1984. PMID: 6097616 Japanese. No abstract available.
• [Arterial infusion chemotherapy with SMANCS].

  Nekohashi T, Maruno J, Sanjou A, Toda G. Nekohashi T, et al. Nihon Rinsho. 2001 Oct;59 Suppl 6:629-33. Nihon Rinsho. 2001. PMID: 11762025 Review. Japanese. No abstract available.
• [Principle and therapeutic effect of lipophilic anticancer agent [SMANCS/lipiodol]: selective targeting with oily contrast medium].

  Maeda H. Maeda H. Gan To Kagaku Ryoho. 1989 Oct;16(10):3323-31. Gan To Kagaku Ryoho. 1989. PMID: 2552930 Review. Japanese.
• [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].

  Takizawa K, Honda M, Obuchi M, Matsuoka S, Shima H, Uchiyama K, Hasebe S, Doai K, Satoh S, Kuniyasu Y. Takizawa K, et al. Gan To Kagaku Ryoho. 1998 Feb;25 Suppl 1:24-9. Gan To Kagaku Ryoho. 1998. PMID: 9512683 Japanese.